ProMIS Neurosciences
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
EBITDA | -7,348 | -238 | 9,276 | |
EBIT | -18,082 | -245 | -4,435 | |
Net Income | -10,117 | -7,348 | -342 | 9,276 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -3,854 | -4,926 | -8,715 | -6,671 |
Cash | 4,510 | 8,364 | 13,291 | 21,536 |
Basic Shares | 32,689 | 34,851 | 34,819 | 30,067 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $8 | $8 |
Gross Profit | -10,444 | -21,781 | -5,843 | |
EBITDA | -16,827,478 | -17,809 | -29,879 | -9,327 |
EBIT | 2,702,098 | -17,837 | -29,895 | -9,373 |
Net Income | 2,778,873 | -17,506 | -12,744 | -9,657 |
Net Change In Cash | 0 | 0 | 8 | 8 |
Free Cash Flow | -27,182 | -14,367 | -17,035 | -9,290 |
Cash | 13,291 | 16,692 | 7,955 | 21,426 |
Basic Shares | 26,461 | 12,292 | 7,502 | 5,785 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$0.39 |
2025-03-31 | -$0.007 |
2024-12-31 | $0.12 |
